Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RUZRV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
40300109 ADC 2
|
|||||
| Synonyms |
ADC 2
Click to Show/Hide
|
|||||
| Organization |
Research and Development, Bristol Myers Squibb.
|
|||||
| Drug Status |
Investigative
|
|||||
| Antibody Name |
undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
NLRP3 Agonist 2
|
Payload Info | ||||
| Therapeutic Target |
NACHT, LRR and PYD domains-containing protein 3 (NLRP3)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||